Hi, what are you looking for?
– In an email to investors seen by the “Financial Times, ” printing pioneer Benny Landa hints he is seeking to oust Teva chairman...
– Brig-Gen (res.) Gil Hirsch claims he is owed the money for mediating Teva’s acquisition of Cephalon. Brigadier General (res.) Gil Hirsch filed a...
– ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), reported that it has acquired 31 previously marketed generic drug products from Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) for...
– Law firm Rigrodsky & Long has filed a class action lawsuit in the US District Court for the Southern District of New York....
– Teva says it will be able to launch generic Viagra in the US in 2017. – – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced...
– Fitch Ratings ranks with Moody’s and S&P and downgraded its debt rating for Teva from “A-” to “BBB+.” – Fitch Ratings has broken...
– In its 2014 guidance Teva provides a pessimistic scenario with generic Copaxone competition, and an optimistic one with Copaxone exclusivity. – CEO Eyal...
– Teva sees $3 billion in potential sales by 2020 from 50 new therapeutic entities. – Dr. Michael Hayden – 50 new products with...
– Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Company Limited ((TSE: 4502) today announced the signing earlier this year of an agreement in...
– The companies have agreed to settle pending patent litigation involving Copaxone in the UK, Netherlands and France. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...